Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today ...
Rheumatology Advisor

Ulviprubart Fails to Meet Endpoints in Inclusion Body Myositis Study

Topline results from the MUSCLE study indicate that ulviprubart did not meet its primary endpoint of mean change in inclusion ...
Healio

Mild to moderate asthma may include high FeNO, eosinophil counts

Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...
Medscape

Mild and Moderate Infections Common in IBD, Rates Vary by Choice of Treatment

Patients with inflammatory bowel disease (IBD) experienced higher rates of mild and moderate infections. Women, smokers, those with multiple comorbidities, and those with exposure to certain IBD ...